Few studies have focused on the association between diet quality scores and the Metabolic Syndrome (MetS), a multi-component condition predictive of cardiovascular diseases (CVD) and death. The present study aims at investigating, in a cross-sectional design, the association between adherence to the French dietary guidelines through an a priori score – the French Nutrition and Health Program-Guideline Score (PNNS-GS) – and cardiovascular risk factors (CVRF) including the MetS and adiposity markers.
7902 French adults participating in the NutriNet-Santé study (an on-going web-based cohort study) attended a clinical and biological examination between January 2011 and November 2012: a fasting blood sample was drawn, blood pressure and body composition (bio-impedance) were measured. Multivariate linear and logistic regression models were used to assess the association between PNNS-GS and CVRF or the MetS.
An increase of PNNS-GS was significantly negatively associated with waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) and serum triglycerides concentrations. From bottom to top quartile of PNNS-GS, SBP decreased from 129.9 to 128.8 mm Hg, DBP from 76.7 to 75.9 mm Hg, serum triglycerides concentrations from 110.8 to 104.6 mg/dL and WC from 94.8 to 90.1 cm for men and 81.3 to 78.9 cm for women. All adiposity markers (waist and hip circumference, % body fat, % trunk fat, % leg fat) were markedly reduced across quartiles of PNNS-GS and linearly. Individuals with a better PNNS-GS (quartile 4 vs quartile 1) were less likely to have the MetS (OR=0.71, 95% CI: 0.56-0.89).
The negative association between a higher adherence to the French dietary guidelines and a number of CVRF, the MetS prevalence and regional adiposity supports the importance of promoting the PNNS dietary guidelines in the population for the prevention of cardiometabolic abnormalities and hence, cardiovascular diseases.
Citation: Lassale C, Galan P, Julia C, Fezeu L, Hercberg S, Kesse-Guyot E (2013) Association between Adherence to Nutritional Guidelines, the Metabolic Syndrome and Adiposity Markers in a French Adult General Population. PLoS ONE 8(10): e76349. https://doi.org/10.1371/journal.pone.0076349
Editor: Reury F.P Bacurau, University of Sao Paulo, Brazil
Received: June 18, 2013; Accepted: August 22, 2013; Published: October 4, 2013
Copyright: © 2013 Lassale et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Région Ile de France (CORDDIM) and Fondation Coeur et Artères. The NutriNet-Santé study is being supported and granted by the following institutions: Ministère de la Santé (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prévention et de l’Education pour la Santé (INPES), Fondation pour la Recherche Médicale (FRM), Institut de Recherche en Santé Publique (IRESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Métiers (CNAM) and Université Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Cardiovascular disease (CVD) is a major public health burden in the western world and is likely to worsen with the increasing prevalence of obesity and type 2 diabetes . Beside individual cardiovascular risk factors (CVRF), the Metabolic Syndrome (MetS) is a multi-component condition that includes a cluster of abnormalities, namely abdominal obesity, high blood pressure (BP), impaired fasting glucose/insulin resistance, high blood levels of triglycerides and low High Density Lipoprotein (HDL) cholesterol . The MetS has been shown to be predictive of type 2 diabetes, atherosclerosis, CVD and mortality [3,4]. In this context, reducing the prevalence of cardiovascular risk factors and the MetS, by acting on diet and physical activity, is of major importance in the prevention of CVD.
A holistic approach of nutritional intake through dietary patterns and dietary scores can capture the combined effects of nutrients in the food matrix [5,6]. The role of the whole diet quality on adiposity and the MetS has been evaluated in observational studies [7,8] and several randomized controlled trials . Adherence to a Mediterranean dietary pattern has been associated with lower body mass index (BMI) and waist circumference (WC) and with lower MetS prevalence and incidence according to recent meta-analyses and reviews [7-9]. Scarce other studies have evaluated the association between CVRF and adherence to dietary guidelines, using dietary scores such as the Dietary Guidelines for Americans Index (DGAI) [10,11] or the Healthy Eating Index (HEI-2005) [12,13]. In France, a score evaluating adherence to the French nutrition and health program (PNNS) dietary guidelines set up by the Ministry of Health in 2001  has been developed, the Programme National Nutrition Santé Guideline Score (PNNS-GS) . This score has shown negative association with the MetS and positive association with HDL cholesterol in a cross-sectional analysis on 1608 French adults but it was significant only among younger adults without medication, hence results were not generalizable to older adults . A prospective analysis on a small sample (n=2763) of adults aged 45y and above from the SU. VI. MAX cohort has shown a predictive value of this score on MetS incidence after 6 years of follow-up (OR=0.91; 95% CI: 0.83-1.00) .
Beyond obesity, regional adiposity is a well-recognized independent CVRF  and it is of interest to study the links between dietary behaviours and adiposity markers. However, to our knowledge, only one study reported associations between the Mediterranean diet and accurate and specific measures of regional adiposity . The aim of the present study was to evaluate in a large sample, in a cross-sectional design, the relationship between adherence to the French nutritional guidelines through the PNNS-GS and a comprehensive range of CVRF, the MetS and regional adiposity markers among French adults participating in the NutriNet-Santé cohort.
Study population and ethics statement
Participants were from the NutriNet-Santé study, an on-going web-based cohort study launched in France in May 2009  aiming at investigating the associations between nutrition and health. Using a dedicated website, adult volunteers (aged >18 years) are followed for at least 10 years (recruitment still on-going). Electronic informed consent is obtained from all participants. All procedures were approved by the International Research Board of the French Institute for Health and Medical Research (IRB Inserm n° 0000388FWA00005831) and the French National Information and Citizen Freedom Committee “CNIL” (n° 908450 and n° 909216). The NutriNet-Santé study’s aims and methods have been described elsewhere . Briefly, at inception, participants complete a set of questionnaires assessing demographic, socioeconomic and lifestyle factors, dietary intake, physical activity (PA), anthropometry and health status.
All participants in the NutriNet-Santé study are invited, on a voluntary basis, for a non-mandatory visit in one of the local centres specifically set up for biological sampling and clinical examination in each region (as of November 2012, 44 hospital-located centres were participating in the collection). Electronic and paper written informed consents are obtained from all subjects attending the visit. All procedures were approved by the “Consultation Committee for the Protection of Participants in Biomedical Research” (C09-42 on May 5th 2010) and the CNIL (n° 1460707).
Apart from data collected at the clinical examination, all data used here were collected at inception of the cohort, through self-administered web-based questionnaires.
Dietary data and physical activity.
Dietary intakes were assessed using three 24-hour records (24HR), randomly allocated over a two-week period, including two week days and one weekend day. The specific web-based tool for self-administered 24HR collection has shown high agreement with the reference method (interview with a dietician). For food groups, the median of Intraclass Correlation Coefficients (ICC) was 0.8 for men and 0.9 for women and for nutrients, the median of energy-adjusted Pearson correlation coefficients was 0.8 . Participants reported all foods and beverages consumed at each eating occasion. Portion sizes were estimated with the help of photographs, derived from a previously validated picture booklet , that represent more than 250 generic foods, corresponding to more than 2000 specific food items, presented in three different portions sizes. Participants could also directly enter the quantity consumed in grams or volume, or use purchased units. Alcohol intake was calculated from the 24HR. The alcohol use frequency questionnaire was used if no consumption was reported in any of the three 24HR days. Consumption of fish and seafood per week was assessed by a specific frequency question as infrequently consumed food.
For each participant, daily mean food consumption was calculated from the three 24HR, weighted for the type of day (week or weekend day). Nutrient intakes were calculated using the ad-hoc NutriNet-Santé composition table including more than 2000 foods . Identification of underreporting participants was based on the method developed by Black . Participants detected as under-reporters were excluded from the analysis (10%). Only a few exclusions were made for over consumption because several controls were made to detect and, if applicable, correct implausibly high consumptions and intakes. Leisure time PA was assessed using the short form of the International Physical Activity Questionnaire (IPAQ), in the French language [25-27]. The metabolic equivalent (MET) measured in minutes per week was computed.
During the visit, participants underwent a clinical examination as well as a fasting blood sampling. The clinical examination included measures of BP, weight, height, WC, Hip Circumference (HC) and bio-impedance measurements.
Height was measured once by a trained technician with a wall-mounted stadiometer without shoes to the nearest 0.5 cm . Weight (to the nearest 0.1 kg) and body composition were measured once with a calibrated impedance body composition analyzer (BC-418MA, TANITA ©, Tokyo, Japan), with participants wearing indoor clothes, barefoot. Adiposity markers measured were the following: % body fat, trunk fat mass (kg) and % trunk fat, leg fat mass (kg) and % leg fat. Leg fat mass (kg) is the sum of fat mass in both legs, while % leg fat is the average % leg fat mass (leg fat mass/total leg mass) for both legs. The trunk to leg fat ratio (TLR) was computed as a measure of upper to lower body fat . Waist circumference was measured as the circumference midway between the lower ribs and iliac crests, and hip circumference as the largest circumference between waist and thighs, both in a standing position and with an inelastic tape (nearest cm).
BP was measured three times after a 5-minute rest, for quality control, with a 1-minute lag between measurements, using an automatic sphygmomanometer Omron HEM-7015IT (Omron, Rosny-sous-Bois, France). The mean of the three measures was used for systolic and diastolic BP (SBP, DBP respectively).
Blood samples were collected after a minimum of 6-h fast; all biochemical measurements were centralized at a single laboratory (IRSA, Tours, France). Fasting blood glucose (hexokinase on C 8000 automat, Abbott, Suresnes, France), total serum cholesterol (cholesterol oxidase C8000, Abbott), HDL cholesterol (direct accelerator C8000, Abbott), serum triglycerides (glycerol kinase C8000, Abbott) were measured and LDL cholesterol was calculated by Friedwald formula .
The following covariates were collected through self-administered questionnaires at baseline, which have been described elsewhere [30,31]. Education referred to the highest achieved diploma, occupation was either current job or most recent occupation for unemployed or retired individuals. Information was also collected on marital status, number of children, smoking status  and on use of medication for hypertension, diabetes or lipid-lowering medication, menopausal status (no, yes, current) and practice of restrictive diet .
Data computation and Statistical analyses
The 15-point PNNS-GS is a validated a priori score reflecting the adherence to the official French nutritional recommendations which has been extensively described elsewhere . Details on computation of this score are in Table S1. Briefly, it includes 13 components: eight refer to food-serving recommendations (fruit and vegetables; starchy foods; whole grain products; dairy products; meat, eggs and fish; fish and seafood; vegetable fat; water vs soda), four refer to moderation in consumption (added fat; salt; sweets; alcohol) and one component pertains to PA [14,15]. Points are deducted for overconsumption of salt (>12g/day), added sugars (>17.5% of energy intake), or when energy intake exceeds the needed energy level by more than 5%. Each component cut-off was that of the threshold defined by the PNNS public health objectives when available  otherwise they were established according to the French Recommended Dietary Allowances .
The MetS status was defined using the recent interim consensus statement  as having at least three of the following criteria: abdominal obesity (waist circumference ≥94 cm for men and ≥80 cm for women), high BP (SBP/DBP ≥130/85 mm Hg or antihypertensive medication), hypertriglyceridemia (≥150 mg/dL or antihypertriglyceridemia medication), low HDL-cholesterolemia (<40 mg/dL for men or <50mg/dL for women) and hyperglycaemia (fasting blood glucose ≥100 mg/dL or antidiabetic medication).
BMI was defined as weight divided by the square of height in meters (kg/m2). BMI categories of the WHO were used to define underweight (BMI<18.5), normal (18.5-24.9), overweight (25-29.9) and obese (≥30) subjects .
Waist to hip ratio (WHR) was calculated (WC/HC) as well as waist-to-height ratio (WHtR) as this index has gained popularity to predict cardiovascular risk .
Characteristics of participants (socioeconomic and anthropometric) were compared between the study sample and the NutriNet-Santé cohort with available data for computation of PNNS-GS, by Student t-tests and chi square tests as appropriate. Quartiles of PNNS-GS were defined for the entire sample and for men and women separately.
To improve normality, all continuous variables were log-transformed. Effect modifications by gender were explored for each analysis.
We used multivariate linear regression to estimate adjusted geometric means of CVRF across quartiles of PNNS-GS. Contrast tests were conducted to detect presence of a linear trend. After assumptions for the application of linear regression were checked, multivariate linear regression models were also used to estimate change in outcome for the increase of 1 point of PNNS-GS.
For comparison purpose between outcomes, z-score of each health index was calculated. We employed exponentiation so that each coefficient could be interpreted as the percent change in z-score for 1 point increase in PNNS-GS . All models were adjusted for the following covariates: sex, age (years), energy intake (kcal/day), season of completion of 24HR (spring, summer, fall, winter), time lag between inception and clinical visit (months), current dieting (yes/no), tobacco smoking (never, former, current smoker), occupation (never employed, farmers or self-employed, manual workers, blue-collar workers, managerial staff), education (up to high school, some college, university graduate) and treatment for the specific outcome (eg, antihypertensive drug when the outcome is SBD or DBP). Finally, BMI was also used as a covariate for analyses of all CVRF, except for WC. Analyses of WC were adjusted for body height.
The same analyses were carried out for adiposity markers stratified by sex, since the relation between diet and adiposity is likely to be sex-specific  and a significant interaction between sex and PNNS-GS was found for most of the adiposity markers. Covariates were the same as previously described, except BMI to avoid over adjustment. Furthermore, the following outcomes were also adjusted for body height: WC, HC, trunk and leg fat (kg). Models for women were further adjusted for menopausal status.
Logistic regression models were used to assess likelihood of having increased risk for MetS according to the level of adherence to dietary guidelines (PNNS-GS taken in quartiles and continuous). A first model was adjusted for the aforementioned covariates without BMI. A second model was further adjusted for BMI to evaluate the association of PNNS-GS with MetS beyond adiposity.
To further investigate the association of each recommendation with MetS and CVRF, a binary variable “recommendation reached” was created for each component, with a value of 1 if the score was ≥ 1 (0.8 for alcohol). OR of having MetS was estimated using the aforementioned models for each component of the PNNS-GS, further adjusted for the total PNNS-GS without the specific component and multivariate linear regression coefficients were estimated for each CVRF.
As of November 2012, out of 12 288 adult subjects of the NutriNet-Santé study who attended the visit between January 2011 and November 2012, 8745 had complete data to compute PNNS‑GS (dietary data from three 24HR, frequency of alcohol and of fish consumption, physical activity), while 7902 had complete data for CVRF needed to assess presence of MetS. At the same date, 63 378 adults with data available for computation of PNNS-GS were included in the NutriNet-Santé study (Table 1).
|Men n=2 264||Women n=5 638||All n=7 902||Cohort n=63378|
|On a weight loss diet||567||25.0||3017||53.5||3584||45.4||30470||48.1||<.0001|
|Living with a partner||1780||78.6||3902||69.2||<.0001||5682||71.9||45891||72.4||0.32|
|Up to high school||807||36.1||1764||32.1||2571||33.3||22071||35.6|
|Season of 24HR||0.38||<.0001|
|Low (<30 min/day)||379||16.7||1304||23.1||1683||21.3||16908||26.7|
|Medium (30-<60 min/day)||500||22.1||1404||24.9||1904||24.1||15392||24.3|
|High (>=60 min/day)||1385||61.2||2930||52.0||4315||54.6||31078||49.0|
Description of the participants
Compared with the NutriNet-Santé participants with data for PNNS-GS computation, subjects in our analysis sample were significantly older (50.8±13.6 vs 42.6 ± 14.3 y), had higher levels of physical activity, a higher PNNS-GS (9.4 ± 1.9 vs 8.9 ± 2.0), were less often smokers, were more often of urban setting, of high educational level and occupied a managerial position (all p-values<0.0001).
The study sample comprised 71% of women (vs 77.6% in the global sample of the NutriNet cohort). Compared to men, women were younger, had a slightly better PNNS-GS, were more often never smokers, were twice as likely as men to be on a diet, had lower physical activity levels and occupied less often a managerial position (all p-values<0.0001).
As described in Table 2, women were twice less likely to be overweight (18.6% vs 35.7%, p<0.0001) and to have MetS (9.5% vs 18.9%, p<0.0001), had lower BP, serum triglycerides and fasting blood glucose than men. Regarding adiposity markers, women had lower WHR, WHtR and TLR but higher % body fat.
|Men n=2264||Women n=5638||All n=7902|
|Time lag between dietary data collection and visit (months)||21.7||10.9||20.6||10.8||<.0001||20.9||10.9|
|Total Serum Cholesterol (mg/dl)||202.8||36.9||213.4||38.1||<.0001||210.4||38.1|
|Blood triglycerides (mg/dl)||108.1||58.6||87.7||41.6||<.0001||93.5||48.0|
|Fasting blood glucose (mg/dl)||93.4||12.8||87.7||10.0||<.0001||89.7||11.1|
|Waist circumference (cm)||91.2||11.2||79.9||11.4||<.0001||83.1||12.4|
|Hip circumference (cm)||98.4||6.9||2261||98.8||9.2||5636||0.01||98.7||8.6||7897|
|Waist to Hip ratio||0.93||0.07||2261||0.81||0.07||5636||<.0001||0.84||0.09||7897|
|Waist to Height ratio||0.52||0.07||0.49||0.07||<.0001||0.50||0.07|
|% body fat||20.1||6.7||2235||29.7||7.7||5590||<.0001||27.0||8.6||7826|
|Trunk fat mass (kg)||9.8||4.9||2235||9.4||4.7||5590||9.5||4.8||7826|
|% trunk fat||21.4||8.0||2235||26.0||9.0||5590||<.0001||24.7||9.0||7826|
|Leg fat mass (kg)||4.7||2.1||8.3||2.9||7.3||3.2||7826|
|% leg fat||18.4||5.4||2235||35.8||6.1||5590||<.0001||30.8||9.9||7826|
|Trunk to leg ratio||2.06||0.53||2235||1.08||0.28||5590||<.0001||1.36||0.57||7826|
|High triglycerides (≥150 mg/dL)or treatment||388||17.1||394||7.0||<.0001||782||9.9|
|High BP (SBP ≥130 and/or DBP ≥85 mm Hg) or treatment||1381||61.0||1789||31.7||<.0001||3170||40.1|
|High fasting blood glucose (≥100mg/dL) or treatment||465||20.5||527||9.4||<.0001||992||12.6|
|Low HDL cholesterol (<40mg/dL males/<50mg/dL females)||173||7.6||595||10.6||<.0001||768||9.7|
|Elevated WC (≥94cm for men, ≥80cm for women)||838||37.0||2467||43.8||<.0001||3305||41.8|
|Treatment for hypercholesterolemia||287||12.7||340||6.0||<.0001||627||7.9|
|Treatment for hypertriglyceridemia||47||2.1||25||0.4||<.0001||72||0.9|
|Treatment for hypertension||380||16.8||481||8.6||<.0001||861||10.9|
|Treatment for type 2 diabetes||59||2.6||38||0.7||<.0001||97||1.2|
Association between PNNS-GS and CVRF
SBP, DBP, triglycerides and WC significantly decreased across quartiles of PNNS-GS (Table 3). No significant trend was found either for serum cholesterol (total, HDL, LDL) or for fasting blood glucose. A 1-point increase of PNNS-GS was associated with a significant reduction in DBP (-1.38% of z-score, P=0.01), triglycerides (-2.16%, P<0.0001) and WC (-4.61%, P<0.0001).
|Quartiles of PNNS-GS|
|Variable||Q1 a||Q2 a||Q3 a||Q4 a||P b||β % c||95% CI|
|Energy intake (kcal/day)d||2118.4 ± 11.0||1937.6 ± 11.0||1849.0 ± 11.5||1812.1 ± 10.7||<.0001|
|SBP (mm Hg)||129.9 (128.7-131.1)||129.0 (127.9-130.2)||129.3 (128.1-130.5)||128.8 (127.7-130.0)||<0.05||-0.58||-1.65||0.51|
|DBP (mm Hg)||76.7 (76.0-77.4)||76.4 (75.7-77.2)||76.3 (75.6-77.1)||75.9 (75.2-76.7)||0.01||-1.38||-2.53||-0.22|
|Total serum cholesterol (mg/dL)||197.7 (194.8-200.6)||199.3 (196.4-202.2)||198.7 (195.8-201.6)||198.2 (195.3-201.1)||0.79||-0.39||-1.55||0.77|
|HDL cholesterol (mg/dL)||57.6 (56.6-58.5)||58.2 (57.2-59.2)||58.1 (57.1-59.1)||58.2 (57.2-59.2)||0.13||0.04||-1.10||1.19|
|LDL cholesterol (mg/dL)||116.3 (113.8-118.8)||118.0 (115.5-120.6)||117.4 (114.9-120.0)||117.3 (114.8-119.9)||0.41||0.04||-1.12||1.23|
|Serum triglycerides (mg/dL)||110.8 (105.2-116.7)||107.4 (101.9-113.1)||107.7 (102.2-113.4)||104.6 (99.3-110.1)||<.0001||-2.16||-3.27||-1.03|
|Fasting blood glucose (mg/dL)||98.5 (97.3-99.7)||98.3 (97.1-99.5)||98.3 (97.1-99.6)||97.9 (96.7-99.2)||0.13||-0.04||-1.15||1.09|
|WC (cm)||86.6 (85.8-87.4)||85.6 (84.8-86.4)||84.8 (84.0-85.6)||83.6 (82.8-84.3)||<.0001||-4.61||-5.59||-3.62|
Even though no significant association was found between PNNS-GS and cholesterol and blood glucose, every CVRF showed significant association with at least one individual dietary recommendation (Table S2).
Association between PNNS-GS and adiposity markers
All adiposity markers displayed a linear decrease across quartiles of PNNS-GS, for both men and women (all p-values for linear trend <0.0001) (Table 4). For men, a dramatic fall in % body fat and in % trunk fat was observed between Q1 and Q4, from 21.2% to 17.7% and from 22.3% to 17.8% respectively. However for most markers for men, values were very similar between Q2 and Q3. As also reflected by the regression coefficients, the PNNS-GS was more strongly associated with adiposity markers in men than in women, e.g. for % trunk fat -9.11% (95% CI: –11.00% to -7.22%) vs -3.47% (95% CI: –4.79% to -2.15%).
|Q1 a||Q2 a||Q3 a||Q4 a||P b||n||β % c||95% CI|
|Men n=2 264|
|BMI kg/m2||26.4 (25.9-26.9)||25.7 (25.2-26.2)||25.7 (25.2-26.2)||25.2 (24.7-25.7)||<.0001||2264||-6.49||-8.40||-4.54|
|WC (cm)d||94.8 (93.3-96.2)||92.5 (91.1-93.9)||92.1 (90.7-93.5)||90.1 (88.8-91.5)||<.0001||2264||-8.37||-10.15||-6.55|
|HC (cm)d||100.4 (99.5-101.3)||99.0 (98.1-99.9)||99.2 (98.3-100.1)||98.1 (97.3-99.0)||<.0001||2261||-6.57||-8.47||-4.63|
|WHR||0.94 (0.94-0.95)||0.93 (0.93-0.94)||0.93 (0.92-0.94)||0.92 (0.91-0.93)||<.0001||2261||-7.41||-9.19||-5.59|
|WHtR||0.54 (0.54-0.55)||0.53 (0.52-0.54)||0.53 (0.52-0.54)||0.52 (0.51-0.52)||<.0001||2264||-8.26||-10.00||-6.47|
|% body fat||21.2 (20.1-22.4)||19.7 (18.7-20.8)||19.7 (18.6-20.7)||17.7 (16.8-18.7)||<.0001||2235||-8.60||-10.40||-6.76|
|trunk fat mass (kg)d||10.2 (9.4-11.0)||9.1 (8.4-9.9)||9.0 (8.3-9.8)||7.7 (7.1-8.4)||<.0001||2235||-7.27||-9.12||-5.38|
|% trunk fat||22.3 (20.9-23.9)||20.5 (19.2-21.9)||20.3 (19.0-21.7)||17.8 (16.6-19.0)||<.0001||2235||-9.11||-11.00||-7.22|
|leg fat mass (kg)d||4.99 (4.73-5.27)||4.58 (4.34-4.83)||4.61 (4.37-4.87)||4.26 (4.03-4.49)||<.0001||2235||-9.05||-10.88||-7.18|
|% leg fat||19.5 (18.8-20.3)||18.4 (17.7-19.2)||18.6 (17.9-19.3)||17.4 (16.8-18.1)||<.0001||2235||-6.81||-8.56||-5.02|
|TLR||2.04 (1.95-2.13)||1.98 (1.90-2.07)||1.95 (1.86-2.04)||1.81 (1.73-1.89)||<.0001||2235||-8.11||-10.10||-6.05|
|Women n=5 638|
|BMI kg/m2||24.0 (23.5-24.4)||23.9 (23.5-24.3)||23.7 (23.3-24.1)||23.3 (22.8-23.7)||<.0001||5639||-2.73||-3.99||-1.45|
|WC (cm)d||81.3 (80.2-82.5)||80.8 (79.7-81.9)||79.9 (78.8-81.0)||78.9 (77.8-80.0)||<.0001||5639||-3.96||-5.21||-2.69|
|HC (cm)d||99.3 (98.4-100.2)||98.9 (98.0-99.8)||98.5 (97.5-99.4)||97.6 (96.6-98.5)||<.0001||5636||-3.28||-4.57||-1.97|
|WHR||0.82 (0.81-0.83)||0.82 (0.81-0.82)||0.81 (0.80-0.82)||0.81 (0.80-0.82)||<.0001||5636||-2.92||-4.22||-1.60|
|WHtR||0.50 (0.49-0.51)||0.50 (0.49-0.50)||0.49 (0.48-0.50)||0.49 (0.48-0.49)||<.0001||5639||-4.09||-5.32||-2.85|
|% body fat||29.5 (28.7-30.4)||29.2 (28.4-30.1)||28.6 (27.7-29.4)||27.6 (26.8-28.5)||<.0001||5590||-4.18||-5.44||-2.89|
|trunk fat mass (kg)d||9.3 (8.6-10.0)||9.1 (8.5-9.9)||8.8 (8.1-9.5)||8.3 (7.6-8.9)||<.0001||5590||-1.20||-1.61||-0.79|
|% trunk fat||24.8 (23.7-25.9)||24.7 (23.6-25.9)||23.9 (22.8-25.0)||22.8 (21.8-23.9)||<.0001||5590||-3.47||-4.79||-2.15|
|leg fat mass (kg)d||8.2 (7.9-8.5)||8.1 (7.8-8.4)||7.9 (7.6-8.2)||7.6 (7.4-7.9)||<.0001||5590||-2.09||-2.81||-1.37|
|% leg fat||36.3 (35.7-37.0)||35.9 (35.3-36.6)||35.4 (34.8-36.0)||34.7 (34.1-35.3)||<.0001||5590||-4.71||-5.91||-3.49|
|TLR||1.04 (1.00-1.07)||1.05 (1.01-1.08)||1.02 (0.99-1.06)||1.00 (0.96-1.04)||0.001||5590||-0.67||-1.12||-0.21|
PNNS-GS and risk of the MetS
The likelihood of having MetS decreased across quartiles and for a 1-point increase of PNNS-GS (Table 5). In men, the lower likelihood of having MetS per 1-point increase in PNNS-GS was stronger than in women. In the whole sample and in men after adjustment for BMI (Model 2), ORs in Q2 were lower than in Q3. In addition, the ORs were closer to 1.00 although they remained significant. In women, OR for a 1-point increase of PNNS-GS was found non-significant in the model adjusted for BMI, however the trend was significant across quartiles and ORs for Q2 vs Q1 and Q3 vs Q1 were significantly lower than 1.
|Q1||Q2a||Q3 a||Q4 a||Continuous b|
|OR||95% CI||OR||95% CI||OR||95% CI||P c||OR||95% CI||P d|
|Model 1 e||ref||0.73||0.59||0.90||0.72||0.59||0.89||0.59||0.48||0.73||<.0001||0.91||0.87||0.94||<.0001|
|Model 2 f||ref||0.75||0.59||0.94||0.78||0.62||0.98||0.71||0.56||0.89||0.0170||0.94||0.90||0.98||0.007|
|Model 1 e||ref||0.66||0.48||0.90||0.77||0.56||1.06||0.43||0.30||0.60||<.0001||0.86||0.80||0.91||<.0001|
|Model 2 f||ref||0.78||0.55||1.11||1.02||0.72||1.44||0.55||0.38||0.80||0.003||0.90||0.84||0.97||0.01|
|Model 1 e||ref||0.79||0.60||1.04||0.69||0.52||0.91||0.72||0.55||0.94||0.05||0.94||0.89||0.99||0.02|
|Model 2 f||ref||0.73||0.54||0.99||0.65||0.48||0.89||0.81||0.60||1.10||0.04||0.97||0.91||1.03||0.30|
As shown in Table S3, the negative association was mainly driven by 5 components of the PNNS-GS: fruits and vegetables, whole grain products, alcohol moderation, salt moderation and physical activity.
Sensitivity analyses for risk of MetS
Two sets of supplementary analyses were carried out to test the robustness of the primary findings. Results are reported in Table S4. First, participants reporting being on a weight loss diet at the inception were excluded (n=3584). Second, participants on medication (antihypertensive, antidiabetic, treatment for hypercholesterolemia and treatment for hypertriglyceridemia) and those who had or have had a chronic cardiovascular disease (heart failure, stable angina, myocardial infarction and stroke) were excluded (n=1437).
Globally, the findings were similar in terms of direction and magnitude despite a loss of power due to sample size reduction leading to some associations which were not statistically significant.
In the present cross-sectional analysis, a better adherence to the French dietary guidelines was negatively associated with the MetS prevalence, with some individual MetS-related traits and with all markers of regional adiposity. These results support a potential beneficial role of official nutritional recommendations disseminated by public health authorities on cardiovascular health status even if inference for causality and temporality cannot be determined. Whereas SBP, DBP, triglycerides and WC were negatively associated with the PNNS-GS, some traits of the MetS, namely fasting blood glucose and serum HDL cholesterol concentrations, were not individually associated with the PNNS-GS.
The present analyses on a French sample of greater size than in the French Nutrition and Health Study (ENNS) study performed on a representative sample of the French population, allowed us to observe significant associations of PNNS-GS with the MetS. In ENNS, an inverse association was found significant only among young adults (<50y) not taking any medication . No interaction between PNNS-GS and age was found in our study. On older participants of the SU. VI. MAX cohort (aged 45y and older at baseline), the PNNS-GS was associated with a 9% reduced risk of developing the MetS after 6 years of follow-up. However, after adjusting for baseline and change in BMI, this association remained significant only for severe MetS (waist criteria +3 or 4 criteria met) . Some studies used other a priori scores in relation with the MetS, such as the HEI-2005  or the DGAI [10,11]. In the US, among 18988 subjects of the NHANES , ORs of having the MetS per quartile of HEI-2005 were similar to our results (Q4 vs Q1, OR=0.65 (0.52, 0.82) where we found 0.71 (0.56-0.89)). The ORs in our study were somewhat stronger than those observed with the DGAI in Tehranian adults (OR Q4 vs Q1 = 0.79 (0.63-0.92)  or in the Frammingham Offspring Study where the negative association was found not significant (OR Q5 vs Q1= 0.81 (0.63, 1.04) .
A lower BP with increasing PNNS-GS is in line with the additive effects obtained from a diet rich in fruits and vegetables (such as the DASH diet) and a limitation in sodium intake .
Serum triglycerides concentrations are mostly influenced by alcohol and carbohydrates intakes [38,39], as confirmed by the analysis of separate components (Table S2). These dietary characteristics are well accounted for in the PNNS-GS computation (3 moderation components: alcohol consumption, sugar sweetened beverages, added sugars) and the results with the global PNNS-GS are particularly salient.
We did not observe any association between blood glucose and diet quality, as Nicklas et al. found with HEI-2005 in the study on NHANES , which is inconsistent with a recent review that showed cross-sectional association of a healthy diet with lower blood glucose . Several arguments can be advanced to explain such discrepancies: the French PNNS recommends eating starchy foods at each meal according to appetite, regardless of their glycaemic index which can impact blood glucose , and consumption of 3 dairy products per day (4 for older people), whose effect on blood glucose is unclear [42,43]. Also, as shown by the low number of obese subjects and the very low number of participants under anti-diabetic drug, this might have led to a lack of power to detect an association with blood glucose.
Finally, no significant association of PNNS-GS with serum HDL–cholesterol concentrations was found. However, the components “physical activity”, “sugar-sweetened beverages” and “added sugars” were found to be positively significantly associated with serum HDL cholesterol concentrations (Table S2), which is coherent with existing evidence [44,45]. On the other hand, alcohol moderation (abstainer or moderate drinking) was negatively associated with serum HDL–cholesterol concentrations, which is not surprising  but might explain the overall non-significant association with PNNS-GS.
A great originality of our results is the data on adiposity status, not only assessed by BMI and WC, but also by % body fat, % trunk fat and TLR. Hence, to our knowledge it is the first study to focus on the relationship between adherence to nutritional guidelines and direct measures of adiposity in a large and diverse sample. We showed a firm decrease in any adiposity marker when PNNS-GS increases. One study in reproductive aged women found similar results on body fat composition assessed by DXA with adherence to a Mediterranean diet (aMED score) . This is in agreement with other studies where adiposity was classically assessed either by BMI or WC, and diet quality referred to a Mediterranean diet [9,47] or dietary guidelines [9,10,12,47-50]. Abdominal adiposity is a key factor of the MetS since accumulation of visceral fat is associated with insulin resistance, inflammation and oxidative stress, which further contribute to the other components of the MetS .
After adjusting for BMI, the association between PNNS-GS and MetS among women was not significant, which suggests that the association was strongly driven by the adiposity component. Also, some factors such as nature of hormonal treatment (contraceptive or hormonal replacement therapies), or genetics that can influence the MetS were not taken into account here, hence residual confounding may remain.
The main strength of our study is the accurate measured biological and clinical data on a relatively large sample of French adults from the general population. Data on body composition provide new insights compared with usual measures of adiposity in cohort studies. Even if bio-impedance analysis is not the reference method to measure body fat composition, good validity indicators of TANITA compared with DXA were observed  and precise data on body composition is seldom available on such a large sample. Dietary intake was estimated through three 24HR which are known to provide accurate estimates of individual intake  while partly limiting measurement error as compared with food frequency questionnaire . In addition, the web-based tool has shown high agreement with the reference method (interview with a dietician) . Whereas dietary nutrients are likely to be interactive or synergistic in the food matrix , which can make it difficult to examine their separate effects on health outcomes, the use of an a priori score partially accounts for the complexity of the diet to detect the effect of the overall dietary behaviour. A priori score show limits due to the arbitrary choice of components and scoring system, hence they are not meant to describe dietary behaviors in an exhaustive way . However, some items taken separately were not associated with the MetS whereas the global PNNS-GS was, illustrating the usefulness to consider diet as a whole when some separate effects cannot be detected .
The first and major limitation is the use of a cross-sectional design, which does not allow drawing conclusions on causal inference, but we adjusted for current diet practice and taking medication, which may limit the probability of reverse causality. Furthermore, reverse causality would lead to the absence of effect or a positive association, e.g. someone who is aware that they have impaired blood lipid levels would pay more attention to their diet and have a better PNNS-GS. Despite this, significant negative associations were found between PNNS-GS and a number of CVRF. Another limitation lies in the non-generalizability of our results as a selection bias might have occurred leading to a potential underestimation of the strength of the associations: participants in the NutriNet-Santé study are volunteers likely to be health-conscious and subjects included in the present analysis may be more healthy since they exhibited different socioeconomic and lifestyle characteristics from the total cohort. However, the percentages of subjects with the MetS and taking specific medication are only slightly lower than in the ENNS study (12.2% in our study vs 14% in ENNS), which is representative of the general population, although it is partly explained by the higher age of our population study (51y vs 45y in ENNS) .
In conclusion, the present cross-sectional study provides new insight on a larger sample of French adults and original data on body composition. The negative association between a higher adherence to the French dietary guidelines and a number of CVRF, the MetS prevalence and regional adiposity supports the importance of promoting the PNNS dietary guidelines in the population for the prevention of cardiometabolic abnormalities and hence, cardiovascular diseases. More studies, especially longitudinal studies, are needed to confirm these findings.
PNNS-GS: components and scores according to PNNS recommendations.
Multivariate linear regression coefficients of CVRF associated with each component of the PNNS-GS, NutriNet-Santé study, France, 2012.
Likelihood of having the Metabolic Syndrome according to components of the PNNS-GS among French adults, NutriNet-Santé study, France, 2012.
We thank all the scientists who carry out the NutriNet-Santé study and the teams, technicians and assistants, who assist their work. We especially thank Laurent Bourhis and Stephen Besseau, data managers, Yasmina Chelghoum, Paul Flanzy and Mohand Ait Oufella, computer scientists, and the team of technicians.
Conceived and designed the experiments: SH PG EKG. Analyzed the data: CL. Wrote the manuscript: CL. Data checking and assisting with the preparation of the manuscript: EKG LF CJ SH PG.
- 1. WHO (2009) Global Health Risks - Technical Report. Geneva.
- 2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644. PubMed: 19805654.
- 3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404. PubMed: 16157765.
- 4. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072. doi:10.1161/CIRCULATIONAHA.105.539528. PubMed: 16275870.
- 5. Hu FB (2002) Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 13: 3-9. doi:10.1097/00041433-200202000-00002. PubMed: 11790957.
- 6. Jacobs DR Jr, Gross MD, Tapsell LC (2009) Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 89: 1543S-1548S. doi:10.3945/ajcn.2009.26736B. PubMed: 19279083.
- 7. Babio N, Bulló M, Salas-Salvadó J (2009) Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr 12: 1607-1617. doi:10.1017/S1368980009990449. PubMed: 19689829.
- 8. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA et al. (2011) The effect of mediterranean diet on metabolic syndrome and its components a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57: 1299-1313. doi:10.1016/j.jacc.2010.09.073. PubMed: 21392646.
- 9. Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D (2011) Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord 9: 1-12. doi:10.1089/met.2010.0031. PubMed: 20973675.
- 10. Fogli-Cawley JJ, Dwyer JT, Saltzman E, McCullough ML, Troy LM et al. (2007) The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome. Am J Clin Nutr 86: 1193-1201. PubMed: 17921402.
- 11. Hosseini-Esfahani F, Jessri M, Mirmiran P, Bastan S, Azizi F (2010) Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism 59: 1833-1842. doi:10.1016/j.metabol.2010.06.013. PubMed: 20667561.
- 12. Nicklas TA, O’Neil CE, Fulgoni VL III (2012) Diet quality is inversely related to cardiovascular risk factors in adults. J Nutr 142: 2112-2118. doi:10.3945/jn.112.164889. PubMed: 23077187.
- 13. Drewnowski A, Fiddler EC, Dauchet L, Galan P, Hercberg S (2009) Diet quality measures and cardiovascular risk factors in France: applying the Healthy Eating Index to the SU.VI.MAX study. J Am Coll Nutr 28: 22-29. doi:10.1080/07315724.2009.10719757. PubMed: 19571156.
- 14. Hercberg S, Chat-Yung S, Chauliac M 2008) The French National Nutrition and Health Program: 2001-2006-2010. Int J Public Health 53: 68-77.
- 15. Estaquio C, Kesse-Guyot E, Deschamps V, Bertrais S, Dauchet L et al. (2009) Adherence to the French Programme National Nutrition Sante Guideline Score is associated with better nutrient intake and nutritional status. J Am Diet Assoc 109: 1031-1041. doi:10.1016/j.jada.2009.03.012. PubMed: 19465185.
- 16. Julia C, Vernay M, Salanave B, Deschamps V, Malon A et al. (2010) Nutrition patterns and metabolic syndrome: a need for action in young adults. French Nutr Health Surv-ENNS: 2006-2007). Prev Med 51: 488-493.
- 17. Kesse-Guyot E, Fezeu L, Galan P, Hercberg S, Czernichow S et al. (2011) Adherence to French nutritional guidelines is associated with lower risk of metabolic syndrome. J Nutr 141: 1134-1139. doi:10.3945/jn.110.136317. PubMed: 21490288.
- 18. Snijder MB, van Dam RM, Visser M, Seidell JC (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35: 83-92. PubMed: 16339600.
- 19. Boghossian NS, Yeung EH, Mumford SL, Zhang C, Gaskins AJ et al. (2013) Adherence to the Mediterranean diet and body fat distribution in reproductive aged women. Eur J Clin Nutr, 67: 289–94. PubMed: 23388669.
- 20. Hercberg S, Castetbon K, Czernichow S, Malon A, Mejean C et al. (2010) The Nutrinet-Sante Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status. BMC Public Health 10: 242. doi:10.1186/1471-2458-10-242. PubMed: 20459807.
- 21. Touvier M, Kesse-Guyot E, Méjean C, Pollet C, Malon A et al. (2010) Comparison between an interactive web-based self-administered 24 h dietary record and an interview by a dietitian for large-scale epidemiological studies. Br J Nutr, 105: 1-10. PubMed: 21080983.
- 22. Le Moullec N, Deheeger M, Preziosi P, Monteiro P, Valeix P et al. (1996) Validation of the photo manual used for the collection of dietary data in the SU. VI.MAX. study Cahier de Nutrition et Diététique.
- 23. NutriNet-Santé coordination (2013) Table de composition des aliments - Etude NutriNet-Santé. Paris: Economica.
- 24. Black AE (2000) Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Relat Metab Disord 24: 1119-1130
- 25. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35: 1381-1395. doi:10.1249/01.MSS.0000078924.61453.FB. PubMed: 12900694.
- 26. Hagströmer M, Oja P, Sjöström M (2006) The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 9: 755-762. PubMed: 16925881.
- 27. Hallal PC, Victora CG (2004) Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc 36: 556. doi:10.1249/01.MSS.0000117161.66394.07. PubMed: 15076800.
- 28. Lohman T, Roche A, Martorell R (1988) Anthropometric Standardization Reference Manual. Human Kinetics Books ed. Champaign, Illinois.
- 29. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502. PubMed: 4337382.
- 30. Touvier M, Méjean C, Kesse-Guyot E, Pollet C, Malon A et al. (2010) Comparison between web-based and paper versions of a self-administered anthropometric questionnaire. Eur J Epidemiol 25: 287-296. doi:10.1007/s10654-010-9433-9. PubMed: 20191377.
- 31. Vergnaud AC, Touvier M, Méjean C, Kesse-Guyot E, Pollet C et al. (2011) Agreement between web-based and paper versions of a socio-demographic questionnaire in the NutriNet-Sante study. Int J Public Health 56: 407-417. doi:10.1007/s00038-011-0257-5. PubMed: 21538094.
- 32. Martin A (2001) Apports nutritionnels conseillés pour la population française. Tec & Doc ed. . Paris: Lavoisier / AFSSA.
- 33. Obesity: preventing and managing the global epidemic. Report of a WHO consultation (2000). WHO Tech Rep Ser 894: i-253.
- 34. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R et al. (2012) Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol 176: 959-969. doi:10.1093/aje/kws172. PubMed: 23144362.
- 35. UCLA Academic Technology Services. How do I interpret regression model when some variables are log transformed? UCLA: Academic Technology Services, Statistical Consulting Group. Available: http://www.ats.ucla.edu/stat/mult_pkg/faq/general/log_transformed_regression.htm. (Accessed 2012 July 14).
- 36. Kimokoti RW, Newby PK, Gona P, Zhu L, Jasuja GK et al. (2010) Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. J Nutr 140: 1287-1293. doi:10.3945/jn.109.120808. PubMed: 20484553.
- 37. Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH (2011) Beyond salt: lifestyle modifications and blood pressure. Eur Heart J 32: 3081-3087. doi:10.1093/eurheartj/ehr379. PubMed: 21990264.
- 38. Grundy SM, Denke MA (1990) Dietary influences on serum lipids and lipoproteins. J Lipid Res 31: 1149-1172. PubMed: 2205699.
- 39. AbouRjaili G, Shtaynberg N, Wetz R, Costantino T, Abela GS (2010) Current concepts in triglyceride metabolism, pathophysiology, and treatment. Metabolism 59: 1210-1220. doi:10.1016/j.metabol.2009.11.014. PubMed: 20060141.
- 40. Nettleton JA, Hivert MF, Lemaitre RN, McKeown NM, Mozaffarian D et al. (2013) Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol 177: 103-115. doi:10.1093/aje/kws297. PubMed: 23255780.
- 41. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T et al. (2008) Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. Am J Clin Nutr 87: 627-637. PubMed: 18326601.
- 42. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB (2005) Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165: 997-1003. doi:10.1001/archinte.165.9.997. PubMed: 15883237.
- 43. Liu S, Choi HK, Ford E, Song Y, Klevak A et al. (2006) A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29: 1579-1584. doi:10.2337/dc06-0256. PubMed: 16801582.
- 44. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347: 1483-1492. doi:10.1056/NEJMoa020194. PubMed: 12421890.
- 45. Siri-Tarino PW (2011) Effects of diet on high-density lipoprotein cholesterol. Curr Atheroscler Rep 13: 453-460. doi:10.1007/s11883-011-0207-y. PubMed: 21901431.
- 46. De Oliveira E, Silva ER, Foster D, McGee HM, Seidman CE, Smith JD et al. (2000) Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102: 2347-2352. doi:10.1161/01.CIR.102.19.2347. PubMed: 11067787.
- 47. Ahluwalia N, Andreeva VA, Kesse-Guyot E, Hercberg S (2012) Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab, 39: 99–110. PubMed: 23062863.
- 48. Kesse-Guyot E, Castetbon K, Estaquio C, Czernichow S, Galan P et al. (2009) Association between the French nutritional guideline-based score and 6-year anthropometric changes in a French middle-aged adult cohort. Am J Epidemiol 170: 757-765. doi:10.1093/aje/kwp174. PubMed: 19656810.
- 49. Kimokoti RW, Gona P, Zhu L, Newby PK, Millen BE et al. (2012) Dietary patterns of women are associated with incident abdominal obesity but not metabolic syndrome. J Nutr 142: 1720-1727. doi:10.3945/jn.112.162479. PubMed: 22833658.
- 50. Lassale C, Fezeu L, Andreeva VA, Hercberg S, Kengne AP et al. (2012) Association between dietary scores and 13-year weight change and obesity risk in a French prospective cohort. Int J Obes (Lond) 36: 1455-1462. doi:10.1038/ijo.2011.264.
- 51. Bozkirli E, Ertorer ME, Bakiner O, Tutuncu NB, Demirag NG (2007) The validity of the World Health Organization’s obesity body mass index criteria in a Turkish population: a hospital-based study. Asia Pac J Clin Nutr 16: 443-447. PubMed: 17704025.
- 52. Ma Y, Olendzki BC, Pagoto SL, Hurley TG, Magner RP et al. (2009) Number of 24-hour diet recalls needed to estimate energy intake. Ann Epidemiol 19: 553-559. doi:10.1016/j.annepidem.2009.04.010. PubMed: 19576535.
- 53. Day N, McKeown N, Wong M, Welch A, Bingham S (2001) Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol 30: 309-317. doi:10.1093/ije/30.2.309. PubMed: 11369735.
- 54. Waijers PM, Feskens EJ, Ocké MC (2007) A critical review of predefined diet quality scores. Br J Nutr 97: 219-231. doi:10.1017/S0007114507250421. PubMed: 17298689.